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Received July 8, 2011; accepted August 3, 2011AbstractBackground: This study examined the effect of propofol on thoracic aortas isolated from endotoxic rats to assess endothelium-dependent and
-independent relaxant responses.
Methods: Adult male Wistar rats were assigned randomly to one of two groups, a saline control group or an experimental group treated with
lipopolysaccharide (LPS, 10 mg/kg intravenously). At 6 hours after saline or LPS infusion, the thoracic aorta was excised and cut into 3-mm
rings. Aortic rings with or without endothelium were suspended in organ baths for isometric tension recording.
Results: Both norepinephrine (NE)-induced vascular contraction and acetylcholine-induced vasodilation were attenuated in aortasfrom LPS-
treated rats. Furthermore, preincubation with propofol caused a rightward shift in the NE concentrationeresponse curve for aortasfrom LPS-
treated rats compared to sham controls. The slow and sustained, but not the initial fast, contractile response to NE was significantly
suppressed by propofol in LPS-treated aortas. In addition, vascular relaxation induced by propofol in LPS-treated aortas was partially suppressed
by inhibitors of either nitric oxide (NO) synthase or soluble guanylate cyclase, but not bypotassium channel inhibitors.
Conclusion: These data suggest that propofol reduces the sensitivity to NE in aortic rings from endotoxic rats. This appears to be caused by (i)
blockade of the extracellular calcium influx rather than a reduction in intracellular calcium release and (ii) an increased response to, at least in
part, NOecGMP in rat aortas.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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11. Introduction
Septic shock has detrimental effects leading to circulatory
failure and abnormal tissue perfusion. Altered tissue perfusion
may be caused by vascular hyporeactivity to adrenergic
agonists. It is believed that enhanced formation of nitric oxide
(NO), principally because of activation of the calcium-
independent, inducible isoform of NO synthase (iNOS),
contributes to the hyporeactivity to endogenous and exogenous
vasoconstrictor agents in septic shock and thus underlies* Corresponding author. Dr. Chin-Chen Wu, Department of Pharmacology,
National Defense Medical Center, Neihu P.O. Box 90048-504, Taipei 114,
Taiwan, ROC.
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doi:10.1016/j.jcma.2012.04.009hypotension. In addition, our previous studies have shown
that Kþ channels are involved in the mechanism of abnormal
relaxation of arteries in rats during endotoxic shock induced
by lipopolysaccharide (LPS).2e4
Propofol (2,6-diisopropylphenol) is a short-acting intrave-
nous anesthetic/hyponotic agent. It has been shown that pro-
pofol causes hypotension via myocardial depression,5,6 direct
vascular relaxation,7,8 and/or a decrease in sympathetic
activity.9 In isolated arteries, propofol decreased vascular tone
and adrenoceptor agonist-induced vasoconstriction.10e12
There are three NOS isoforms: neuronal NOS (nNOS),
endothelial NOS (eNOS), and iNOS.13 The release of NO
induced by eNOS in the vascular endothelium partially
contributes to propofol-induced relaxation.11,12,14 By contrast,
vasodilation in response to propofol has been attributed tohinese Medical Association. All rights reserved.
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smooth muscle cells, reflecting inhibition of the Ca2þ influx
through voltage- or receptor-gated Ca2þ channels.12,15,16
Propofol is widely used not only in anesthesia but also in
critical care units.17 Therefore, whether arterial sensitivity to
vasoconstrictors and/or vasodilators can be modulated by
propofol is an important issue in ill patients.In this study, we
investigated the effect of propofol on norepinephrine (NE)-
induced contractile responses in thoracic aortas isolated from
Wistar rats treated with LPS. In addition, we assessed whether
propofol can modulate the action of NE by studying
endothelium-dependent and -independent relaxant responses.
2. Methods
Sixty male Wistar rats (250e300 g) were purchased from
BioLASCO Taiwan (Taipei, Taiwan). The animals were
maintained on a 12-hour light/dark cycle and were given free
access to water and standard rat chow. Animal experiments
were approved by our institutional and Committee on the Care
and Use of Animals (National Defense Medical Center, Taipei,
Taiwan, ROC) and all animals received humane care accord-
ing to the criteria of the National Academy of Sciences.
The rats were anesthetized by intraperitoneal injection of
urethane (1.2 g/kg) and body temperature was maintained at
approximately 36 C with a heating pad. The trachea was
cannulated to facilitate respiration. The right carotid artery
was cannulated and connected to a pressure transducer
(P23ID, Statham, Oxnard, CA, USA) for measurement of
mean arterial blood pressure and heart rate, which were dis-
played on a polygraph recorder (MacLab/4e, ADInstruments,
Castle Hill, Australia). The left jugular vein was cannulated
for administration of endotoxin or vehicle. On completion of
the surgical procedure, cardiovascular parameters were
allowed to stabilize for 20 min. After recording baseline
hemodynamic parameters, animals received Escherichia coli
LPS (10 mg/kg intravenous infusion for 10 minutes) or normal
saline (same volume as LPS) and were monitored for 6 hours.
Bacterial LPS (E. coli serotype 0127:B8, L3127) was obtained
from Sigma Chemical (St. Louis, MO, USA).
At 6 hour after injection of saline or LPS, thoracic aortas
were isolated from sham controls and rats treated with LPS
under anesthesia. The thoracic aorta was cleaned of adhering
periadventitial fat in ice-cold (4 C) Krebs solution and was
cut into rings of approximately 3 mm in length, with four
aortic rings assessed from one rat.The Krebs solution (pH 7.4)
consisted of (mM): NaCl 118, KCl 4.7, KH2PO4 1.2, MgSO4
1.2, NaHCO3 25, CaCl2 2.5 and glucose 11. To analyze
endothelium-independent effects of the drug, the endothelium
was removed from some by gently rubbing the intimal
surface.2 For the remaining rings, care was taken not to touch
the inner surface of the blood vessel. Aortic rings were
mounted in 20-mL organ baths containingoxygenated (95%
O2e5% CO2) Krebs solution kept at 37
C. Two S-shaped
stainless steel hooks were inserted through the lumen; the
lower hook was fixed and the upper one was attached to
anisometric force displacement transducer (Grass FT03transducer, Grass Technologies, Quincy, MA, USA). The
resting tension was set to 2 g (determined to be optimal in
preliminary lengthetension experiments) and preparations
were allowed to equilibrate for at least 60 minutes. During this
incubation period, each ring was washed three times with fresh
Krebs solution. Endothelial integrity or denudation was
confirmed in each ring by testing relaxation induced by
acetylcholine (ACh, 1 mM) after precontraction with the alpha-
adrenergic agonist NE (100 nM). Lack of a relaxation
response to ACh was considered as evidence that the endo-
thelium had been removed. After this procedure, the rings
were washed and allowed to re-equilibrate to baseline tension
for 45 minutes.
In the first series of experiments, eight rats were used in
each sham control groupand each group of rats treated with
LPS.Cumulative NE concentrationeresponse curves were
calculated without propofol. After washing three times with
fresh Krebs solution for 30 minutes, aortic rings were then
incubated with or without propofol (10 mM) in fresh Krebs
solution for 20 minutes, and cumulative NE concen-
trationeresponse curves were calculated for all vessels with or
without endothelium. It was noted that vascular reactivity was
not altered by repetition of agonist stimulation, and that pro-
pofol did not modify the basal tension of rings from sham and
LPS-treated rat aortas during the time course of incubation
before agonist addition.
In the second series of experiments, eight rats were also
used in each sham control groupand each group of rats treated
with LPS. To study the role of propofol in extracellular
calcium influx and intracellular store release induced by NE,
endothelium-intact aortic rings were incubated with or without
propofol (10 mM) in fresh Krebs solution for 20 minutes and
then the rings were contracted with NE (1 mM). When
maximal contraction was attained, rings were washed three
times with Ca2þ-free Krebs solution and the protocol was
repeated after a 45-minute equilibration period in Ca2þ-free
solution. The calcium-free solution was of the same compo-
sition as Krebs solution except that CaCl2 was omitted. The
maximal NE-induced contraction of aortic rings in normal and
Ca2þ-free Krebs solution was termed S and F phase, respec-
tively, as previously described.18 The fast initial phase
(F phase) of NE-induced contraction depends on a common
intracellular Ca2þ store, and the slow tonic phase (S phase) of
NE-induced contraction mostly depends on the extracellular
Ca2þ influx.19e21
In the third series of experiments, eight rats were used in
each sham control groupand each group of rats treated with
LPS. Cumulative concentrationeresponse curves for ACh
(1 nM to 1 mM) and propofol (1 nM to 10 mM) were obtained
for aortic rings precontracted with NE in endothelium-intact
and -denuded preparations. The NE-induced contraction
level in preparations obtained from the LPS-treated group was
adjusted to the same level as that in the sham group. There-
fore, 100 nM NE was used in the sham group and 1 mM NE in
the LPS-treated group. The vasodilatory response to propofol
was expressed as a percentage of the initial contraction
induced by NE.
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each sham control groupand each group of rats treated with
LPS. To clarify the role of the NOecGMP pathway and Kþ
channels in propofol-induced vasodilation, inhibitors of NO
synthase (Nu-nitro-L-arginine methyl ester, L-NAME;
300 mM), soluble guanylate cyclase (1H-[1,2,4]oxadiazolo
[4,3-a]quinoxalin-1-one, ODQ; 1 mM), or Kþ channels (tet-
raethylammonium, TEA; 1 mM) were used. Endothelium-
intact aortic rings were incubated with each inhibitor for 20
minutes and then the vasodilatory response to propofol
(10 mM) was measured for rings precontracted with NE.
All drugs were obtained from Sigma (St. Louis, MO, USA).
Propofol and ODQ were initially dissolved in dimethylsulf-
oxide (DMSO) and further diluted in distilled water. Control
experiments indicated that DMSO had no direct effect in the
final concentrations applied. All other stock solutions were
prepared in distilled water. Drug concentrations are expressed
as final molar concentrations in the organ bath.
All results are expressed as mean  SEM for n observa-
tions, where n is the number of rats from which blood vessels
were obtained. Statistical analysis of the data was performed
by generalized estimating equations to account for repeated
measures per rat with post hoc analysis using the Bonferroni
correction or Student’s t test, as appropriate. A p value < 0.05
was considered statistically significant.
3. Results
Cumulative concentrations (1 nM to 3 mM) of NE induced
vasoconstriction in a dose-dependent manner in aorta from
sham rats, with maximum contraction achieved at 1 mM
(Fig. 1A). ACh caused dose-dependent vasodilation in aortic
rings precontracted with NE (Fig. 1B). In LPS-treated rat-
s,however, NE-induced vasoconstriction and ACh-induced
vasodilation were significantly attenuated (both p < 0.001,
Fig. 1A,B).log [NE] (M)
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Fig. 1. Concentrationeresponse curves for (A) norepinephrine (NE) and (B) acety
Values are mean  SEM for n ¼ 8 animals per group. #p <0.001, LPS-treated vePreincubation of aortic rings from sham rats with 10 mM
propofol caused a significant decrease in NE-induced vaso-
constriction compared to sham controls only at 10 nM NE
( p < 0.001, Fig. 2A). However, propofol significantly
decreased NE-induced vasoconstriction (10 nMe1 mM NE) in
aortic rings from LPS-treated rats ( p ¼ 0.05, Fig. 2C). Thus,
propofol effectively enhanced LPS-induced hyporeactivity to
NE in intact aortic rings. In denuded aortic rings, pre-
incubation with 10 mM propofol also caused a decrease in NE-
induced vasoconstriction at the lower concentrations (1 and
10 nM) in sham rats ( p < 0.001, Fig. 2B). In LPS-treated rats,
preincubation with propofol significantly decreased vasocon-
striction induced by 10 nMe1 mM NE in denuded aortic rings
( p < 0.01, Fig. 2D).
Comparison of aortas with and without endothelium
revealed that endothelium removal increased the contractile
response to NE (1e10 nM) in sham controls ( p < 0.05) but
not in LPS-treated ( p ¼ 0.3) rats. However, endothelium
removal did not significantly affect NE-induced vasocon-
striction in aortic rings pretreated with propofol (10 mM) in
sham controls ( p ¼ 0.07) and LPS-treated rats ( p ¼ 0.46).
Thus, propofol modulated endothelium-dependent vascular
reactivity in aortas from sham controls, but not from LPS-
treated rats.
NE evoked an initial fast phase of contractionin
endothelium-intact aortic rings from sham rats, and this was
significantly attenuated in endothelium-intact rings from LPS-
treated rats ( p < 0.05, Fig. 3A). Preincubation of aortic rings
with 10 mM propofol significantly decreased the initial
responses to NE in sham controls ( p ¼ 0.01, Fig. 3A), but not
in LPS-treated rats. However, the S phase of contraction to NE
was not significantly attenuated in aortas from LPS-treated
rats when compared to sham controls ( p ¼ 0.15, Fig. 3B).
Preincubation of aortic rings with 10 mM propofol signifi-
cantly decreased the slow tonic responses in both sham
controls ( p ¼ 0.03) and LPS-treated rats ( p ¼ 0.01; Fig. 3B).log [ACh] (M)
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Fig. 2. Concentrationeresponse curves for norepinephrine (NE) in (A,B) sham and (C,D) lipopolysaccharide (LPS)-treated rat aortic rings with (þE) and without
endothelium (eE) in the presence and absence of propofol (10 mM). Values are mean  SEM for n ¼ 8 animals per group. #p < 0.001, yp < 0.01, *p < 0.05,
pretreatment with versus without propofol.
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dependent relaxation in endothelium-intact and -denuded
rings from sham (Fig. 4A) and LPS-treated rats (Fig. 4B).
Endothelium removal significantly decreased the relaxation
response to propofol in aortic rings from sham rats ( p < 0.01)
but not from LPS rats ( p ¼ 0.158). This suggests that the
aortic relaxation response to propofol was endothelium-
dependent in sham rats, but endothelium-independent in LPS
rats. In the presence of either L-NAME or ODQ, the propofol-
induced vasodilation in aortas from sham controls and LPS-
treated rats was reduced ( p < 0.05, Fig. 5), suggesting that
propofol-induced relaxation was, at least in part, via the
NOecGMP pathway. However, propofol-induced vasodilation
in aortas from sham and LPS-treated rats was not significantly
affected by the presence of TEA (Fig. 5).
4. Discussion
This study provides a number of interesting observations.
First, propofol modulated vascular reactivity in aortas fromLPS-treated rats. Propofol decreased the magnitude of NE-
induced vasoconstriction in these vessels compared with
those from sham controls. Similar findings were reported by
Grissom and colleagues with respect to halothane (an inhala-
tion anesthetic agent) in phenylephrine-contracted aortic strips
from LPS-treated rats,22 suggesting that the contractile
response of the aorta during LPS-induced septic shock is more
sensitive to the effects of anesthetic agents compared to
normal aorta. Second, our study shows that preincubation with
propofol can decrease vascular reactivity in LPS-treated rats
during NE contraction, largely via blockade of the extracel-
lular calcium influx, but apparently not via blockade of
intracellular calcium release. In addition, propofol-induced
relaxation partly involved the NOecGMP pathway, but not
Kþ channel activation, in aortas isolated from both sham
controls and LPS-treated rats.
Several changes in vascular responses causing abnormal
reactivity have been demonstrated in LPS-treated rats, and
may help to explain the difference in propofol effects between
LPS-treated and sham rats. These changes include lower
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Fig. 3. Effects of propofol on extracellular calcium influx and intracellular store release induced by norepinephrine (NE). The fast initial phase (F phase) of NE-
induced aortic contraction in Ca2þ-free solution depends on a common intracellular Ca2þ store and the slow tonic phase (S phase) of NE-induced contraction
depends on Ca2þ influx in aortic rings from sham and lipopolysaccharide (LPS)-treated rats. Values are mean  SEM for n ¼ 8 animals per group.*p < 0.05,
pretreatment with versus without propofol; #p < 0.05, LPS-treated versus sham group.
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overproduction of vasodilators under pathophysiological
conditions.1,23,24 Previous studies have demonstrated that the
vascular hyporeactivity seen in endotoxic shock reflects
anoverexpression of iNOS and abnormal activation of Kþ
channels, in particular the large-conductance Ca2þ-activated
Kþ (BKCa)-channel, ATP-sensitive K
þ (KATP)-channel, and
Naþ-Kþ pump.24e26 In the present study, preincubation with
propofol reduced the sensitivity of NE-induced vasoconstric-
tion in aorta more effectively for LPS-treated rats than for
sham controls. This effect was not significantly altered by the
endothelium. These findings suggest that the modulatory effectSham
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Fig. 4. Concentrationeresponse curves for propofol in sham and lipopolysaccharid
were precontracted using norepinephrine (NE). Relaxation is expressed as the
mean  SEM for n ¼ 8 animals per group. yp < 0.01, with versus without endotof propofol against NE-induced vasoconstriction in LPS-
treated rats may mainly involve an effect on smooth muscle.
The vascular contraction induced by NE reflects intracel-
lular calcium elevation, mainly due to calcium release from
the sarcolemma reticulum (SR) and increased extracellular
calcium influx.20 Bolton19 and Van Breemen and co-workers21
independently suggested that NE elicits Ca2þ release from the
SR to cause contraction (F phase), then opens receptor-
operated Ca2þ channels, leading to Ca2þ influx and sus-
tained contraction (S phase).20 It has been shown that propofol
can decrease Ca2þ influx in smooth muscle through either
voltage-gated Ca2þ channels or/and receptor-mediatedLPS
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Fig. 5. Effects of Nu-nitro-l-arginine methyl ester (L-NAME), 1H-[1,2,4]
oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and tetraethylammonium (TEA) on
propofol-induced relaxation in aortic rings from sham and lipopolysaccharide
(LPS)-treated rats. For rings precontracted with norepinephrine (NE), relaxa-
tion induced by propofol (10 mM) was examined in the presence and absence
of L-NAME (300 mM), ODQ (1 mM), or TEA (1 mM).Relaxation is expressed
as the percentage response to the initial contraction induced by NE. Values are
mean  SEM for n ¼ 6 animals per group. *p < 0.05, pretreatment with
versus without inhibitors.
267C.-M. Tsao et al. / Journal of the Chinese Medical Association 75 (2012) 262e268channels, depending on which is predominantly present.15,16
In the present study, preincubation of aorta with propofol
suppressed both the initial and the sustained contraction to NE.
However, propofol only suppressed the slow and sustained, but
not the fast initial, contractions in aorta from LPS-treated rats.
Thus, the effect of propofol may predominantly involve inhi-
bition of the extracellular Ca2þ influx in LPS-treated rats,
while it reduces both intracellular Ca2þ release and extracel-
lular Ca2þ influx in sham controls. It has been observed that
the intracellular Ca2þ concentration can be decreased by NO
when mice aortic segments were contracted with phenyleph-
rine.27 Therefore, propofol may modulate Ca2þ movement in
rat aortic rings through NO.
In the current study, propofol induced endothelium-
dependent vasodilation in aortic rings from sham rats, which
may have partly involved the NOecGMP pathway. Similar
results have been observed in pulmonary and coronary artery
rings, showing that propofol-induced relaxation partly depends
on the endothelium.28,29 In addition, some reports have
proposed that propofol-induced relaxation reflects stimulation
of NO release from endothelial cells,13,29,30 and that propofol-
induced hyperpolarization reflects activation of Kþ chan-
nels.31,32 By contrast, other reports suggest that propofol
relaxes arteries in an endothelium-independent manner.11,15,16
In this study, we found that propofol induced comparable
relaxation in aortas from LPS-treated rats with and without
endothelium, and this vasodilation was significantly attenuated
byinhibitors of NO synthase and of soluble guanylate cyclase.
By contrast, the vasodilation was not significantly suppressed
by non-specific Kþ channel blockers. It has been shown that
NO induces vascular relaxation via cGMP in vascular smooth
muscle and is an important mediator of vascular tone during
sepsis, as iNOS is upregulated during the late stage.33 Thus,
we speculate that propofol-induced vasodilation in aortic ringsfrom LPS-treated ratscould be modulated by smooth muscle-
derived NO (via iNOS) and cGMP.
These vascular effects of propofol occur at a clinically
relevant concentration (10 mM), as the typical peak serum
concentration of propofol during anesthesia ranges from 2 to
10 mg/mL (approx. 10e60 mM) in humans.34 However, the
free drug concentration is markedly reduced by approximately
97% by protein binding.35 Therefore, direct extrapolation of
our results to a clinical situation requires some caution.
In conclusion, our results confirm that propofol differen-
tially modulates vascular contractile responses to agonists in
arterial tissues from LPS-treated and control rats. Suppression
of NE-induced vascular contraction by propofol in the aorta
was greaterin endotoxemia than in the normal condition,
associated with a defect in extracellular Ca2þ influx and an
increase in response to NOecGMP in aortas from endotoxe-
mic rats. These findings may further explain, at least in part,
why there is a higher incidence of hypotension in critically ill
patients when propofol is used to induce anesthesia.
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